CLS Cheat Sheet 2026

The 30 highest-yield CLS facts, distilled from real exam questions. Print it, save it as a PDF, or study it here — free, no sign-up.

150 questions
180 min time limit
70% to pass
  1. In the classification of dyslipidemias, 'dysbetalipoproteinemia' is synonymous with which Fredrickson phenotype? Type III
  2. Which patient population is most likely to benefit from fenofibrate therapy as evidenced by subgroup analyses from clinical trials? Patients with combined dyslipidemia (high TG + low HDL)
  3. A patient is found to have borderline high TG (150–199 mg/dL) at a routine screening. Which secondary cause should be ruled out first given its high prevalence? Poorly controlled type 2 diabetes mellitus
  4. Why is weight management important in cardiovascular care? It supports cardiovascular health
  5. Which genetic mutation is most commonly associated with familial hypercholesterolemia in children? LDLR loss-of-function
  6. A patient with nephrotic syndrome develops hyperlipidemia primarily due to which mechanism? Compensatory hepatic lipoprotein overproduction due to low oncotic pressure
  7. Which genetic mutation is the most frequent cause of familial hypercholesterolemia in the general population? LDLR mutations
  8. What is the expected LDL-C reduction with ezetimibe monotherapy? 15–25%
  9. In a patient with familial hypercholesterolemia (FH) and LDL-C of 210 mg/dL despite maximum statin plus ezetimibe, which is the most appropriate next step? Add a PCSK9 inhibitor (evolocumab or alirocumab)
  10. A 14-year-old male with heterozygous FH initiates statin therapy. What baseline laboratory test is most important to obtain? Creatine kinase and hepatic transaminases
  11. In patients with HIV on antiretroviral therapy, which statin is preferred due to minimal interaction with protease inhibitors? Pravastatin or rosuvastatin
  12. What is the goal of antihypertensive therapy in cardiovascular risk? Reduce stroke and heart attack risk
  13. What is a key principle of secondary causes of dyslipidemia in Clinical Lipid Specialist Certification practice? Applying structured methodologies based on evidence and best practices
  14. Anorexia nervosa is associated with which lipid pattern? Elevated total cholesterol and LDL-C with reduced bile acid excretion
  15. What is the significance of measuring Lp(a) in children with familial hypercholesterolemia? It identifies those at higher cardiovascular risk requiring more aggressive therapy
  16. Which strategy best addresses health literacy barriers when educating patients about lipid management? Use simple language, visual aids, and confirm comprehension with teach-back
  17. In familial hypercholesterolemia (FH), what is the most common molecular defect? Loss-of-function mutation in the LDL receptor gene
  18. Which atypical antipsychotic is most strongly associated with secondary hypertriglyceridemia and metabolic syndrome? Clozapine
  19. A patient with alcoholism presents with TG of 1,800 mg/dL. The primary mechanism of alcohol-induced hypertriglyceridemia is: Increased hepatic fatty acid synthesis and VLDL secretion with inhibited LPL
  20. How should CLS professionals measure success in novel lipid-lowering therapies? Using defined metrics, benchmarks, and regular evaluation against established goals
  21. What challenge is most commonly encountered in secondary causes of dyslipidemia within Clinical Lipid Specialist Certification practice? Resistance to change and difficulty maintaining consistency across stakeholders
  22. Which genetic disorder is characterized by the accumulation of IDL and causes both hypercholesterolemia and hypertriglyceridemia with palmar xanthomas? Type III hyperlipoproteinemia (familial dysbetalipoproteinemia)
  23. Which lipid panel component most directly reflects the number of atherogenic lipoprotein particles when LDL-C and triglycerides are discordant? Apolipoprotein B
  24. Inclisiran is a small interfering RNA (siRNA) therapy that targets PCSK9. What is its primary mechanism of action? Degrades PCSK9 mRNA in hepatocytes to reduce PCSK9 synthesis
  25. A patient with hypothyroidism presents with TC 320 mg/dL and LDL-C 240 mg/dL. What is the most appropriate first step in management? Treat the underlying hypothyroidism and recheck the lipid panel
  26. Which condition is a major contributor to cardiovascular risk? Diabetes mellitus
  27. Which lipoprotein pattern is characterized by elevated VLDL and chylomicrons, causing a creamy supernatant and turbid infranatant on refrigerated plasma? Fredrickson Type V
  28. What is the most appropriate initial management for a patient presenting with triglycerides of 850 mg/dL to prevent acute pancreatitis? Strict dietary fat restriction plus fibrate therapy plus omega-3 fatty acids
  29. Pitavastatin is unique among statins primarily because it is metabolized by which enzyme pathway, resulting in minimal drug interactions? Primarily glucuronidation with minimal CYP involvement
  30. In the exogenous lipid pathway, chylomicrons are assembled in which cells? Intestinal enterocytes
Turn these facts into recall:
Was this helpful?